• Adding bevacizumab to chemotherapy increases resectability of colorectal liver metastases

    9 days ago - By Healio

    The addition of bevacizumab to modfied FOLFOX6 improved liver metastases resection rates and survival outcomes among certain patients with colorectal liver metastases, according to study results published in Journal of Clinical Oncology.
    “To our knowledge, this is the rst randomized controlled trial to test whether the introduction of bevacizumab added to chemotherapy will increase the resection rate of liver metastases for patients with RAS-mutant colorectal liver metastases,” Wentao Tang, MD, clinical researcher in the department of
    Read more ...


  • Pulmonary endarterectomy improves outcomes in patients with CTEPH

    10 days ago - By Healio

    Patient-reported outcomes significantly improved after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension, or CTEPH, according to results published in the European Respiratory Journal.
    “Treatment options for managing CTEPH have broadened to include pulmonary endarterectomy, balloon pulmonary angioplasty, riociguat and medical therapies for pulmonary arterial hypertension used off-label,” Michael Newnham, MD, respiratory clinical lecturer at the Institute of Applied Health Research at the University of Birmingham, U.K., and
    Read more ...